172026-08

Dual Growth in Turnover and Profit | CMS (867.HK, 8A8.SG) 2026 Interim Performance Report in One Picture

Secretary of the CPC Hainan Provincial Committee Feng Fei Visits Dermavon Hainan

2026-08-11

On August 10, 2026, Mr. Feng Fei, Secretary of the Hainan Provincial Committee of the Communist Party of China (CPC), headed a delegation for an inspection tour of Dermavon Hainan, a skin health subsidiary of China Medical System. The delegation conducted an on-site review of the company’s development, innovative R&D, and construction progress of Hainan R&D and Manufacturing Base. The inspection tour was accompanied by Fan Shaojun, Member of the Standing Committee of the Hainan Provincial Committee and Secretary of the Haikou Municipal Committee; Zhang Yong, Mayor of Haikou; Yang Zhongcheng, Director-general of the Policy Research Office of the Hainan Provincial Committee; Qi Shuli, Director of the Hainan Development and Reform Commission; Ji Tiejun, Director of the Hainan Medical Products Administration; Wang Yuan, Deputy Director-General of the Hainan Provincial Department of Industry and Information Technology. During the inspection, Huang Anjun, Executive Director and CEO of Dermavon, gave a briefing to Secretary Feng and the accompanying delegation on the Company’s […]

CMS: Rxilient Obtained Commercialization Rights for Dermatology Improved New Drug Finjuve and Branded Drug Ciclopoli in Southeast Asia and Other Markets

2026-07-27

Finjuve, animproved new drug, is the first and only topical finasteride product worldwide approved for the treatment of androgenetic alopecia. Its efficacy is comparable to oral finasteride, while showing 100-fold lower systemic exposure and less impact on serum DHT levels compared with oral finasteride, offering an effective hair-loss treatment option with lower risk. Ciclopoli, a branded drug, uses patented HPCH water-soluble transungual technology. It does not require nail filing or organic solvents to remove the film, combining strong efficacy, safety, and convenience, and offering a superior topical treatment option for onychomycosis patients. Leveraging itsestablished registration and commercialization capabilities across Southeast Asia, Rxilient will accelerate the launch of both products, injecting new momentum into business growth in the region.   Recently, the Southeast Asia business subsidiary of China Medical System (“CMS”), Rxilient Medical Pte. Ltd. (“Rxilient”), entered into a partnership with Polichem S.A., a subsidiary of Almirall S.A. (ALM), a global biopharmaceutical company focused on medical dermatology. Rxilient obtained […]
Dual ESG Recognition: CMS Named Among “China ESG Leaders 2026” and Honored with the “Green Supply Chain Leadership Award”

Dual ESG Recognition: CMS Named Among “China ESG Leaders 2026” and Honored with the “Green Supply Chain Leadership Award”

2026-07-17

Recently, SynTao Green Finance officially released the Steady Progress for a Sustainable Future: China ESG Leaders Annual Report 2026. China Medical System Holdings Limited (“CMS” or “the Group”) was successfully named among “China ESG Leaders 2026”, recognized for its long-term dedication and outstanding practices in the Environmental, Social, and Governance (ESG) fields. Additionally, CMS was honored with the “Green Supply Chain Leadership Award” in the ESG selection hosted by Stockstar. This double recognition underscores the strong affirmation from professional institutions and the market for the Group’s sustainable development initiatives. Published by SynTao Green Finance, a leading ESG rating agency in China, the Steady Progress for a Sustainable Future: China ESG Leaders Annual Report 2026 is widely recognized for its high credibility and influence. Stockstar’s “ESG New Benchmark Awards”, themed “Innovation, Co-governance, Long-term Value”, introduced the “Green Supply Chain Leadership Award” for the first time. The award specifically focuses on corporate practices and achievements in building green, low-carbon, and responsible supply chains. As […]

CMS Charity | Standing Together with Guangxi: Medical Supplies Worth Over RMB 1 Million Rushed to Disaster Areas

2026-07-13

Recently, affected by Typhoon Maysak combined with sustained heavy rainfall, several regions in Guangxi experienced rising river levels, urban and rural flooding, and other hazards. Transportation and public services were disrupted to varying degrees, and local residents faced mounting pressures on daily life and primary healthcare access. As floodwaters recede and cleanup operations progress, post-disaster health protection efforts have entered a critical phase, including ensuring safe drinking water, environmental disinfection, and preventing intestinal diseases. In this race against the storm, CMS responded swiftly and mobilized resources without delay. Through the Shenzhen Charity Federation, the company donated medical supplies worth over RMB 1 million to the affected areas, including disinfectants and anti-diarrheal medications, to support essential healthcare services and primary-level health protection in the disaster-hit areas. The supplies have been dispatched to the front lines under the Federation’s coordination, expedited to reach those in need and contribute to disaster relief and post-disaster recovery. Safeguarding life and […]
CMS Charity | Love Like Starlight: CMS Continues to Care for Children’s Growth

CMS Charity | Love Like Starlight: CMS Continues to Care for Children’s Growth

2026-06-01

Growing toward the light, together in warmth. With International Children’s Day approaching, China Medical System Holdings Limited (“CMS”), through its subsidiary Shenzhen Kangzhe, continued its long-standing philanthropic initiatives. Via the Charity Association of Shenzhen Nanshan, CMS donated funds to the Star Exceptional Children Rehabilitation Center in Nanshan District, Shenzhen. The donation will be used to upgrade teaching aids, add rehabilitation equipment, and provide support for frontline teachers—helping improve learning, rehabilitation, and living conditions for exceptional children. Over the years, CMS has stood side-by-side with the Center, witnessing every small step of progress in the rehabilitation and growth of these children. This enduring commitment stems from a deep compassion for special-needs children and a profound understanding of philanthropic values: their development demands patience, sustained support, and collective care from society. In addition, CMS donated 10 computers to the Green & Shine Foundation to help improve educational facilities in schools across central and western China, supporting daily teaching […]

CMS Included in S&P Global Sustainability Yearbook (China Edition) for the Fourth Consecutive Year

2026-04-14

S&P Global, an internationally recognized rating agency, recently released the Sustainability Yearbook (China Edition) 2026. China Medical System (“CMS” or the “Group”) stood out among nearly 1,800 companies and was successfully included for the fourth consecutive year, underscoring the Group’s long-term resilience and comprehensive strengths in sustainable development. （Source：S&P Global）   CMS integrates the United Nations Sustainable Development Goals (“SDGs”) into the Group’s ESG strategy, guided by top-level planning, is driving a more sustainable transformation across the entire value chain. We are committed to improving accessibility and equity in healthcare, and continue to increase R&D investment in innovative medicines and treatments for rare diseases, addressing unmet clinical needs through scientific innovation. At the same time, we remain dedicated to inclusive healthcare, responding to societal needs through concrete actions and fulfilling the responsibilities expected of a pharmaceutical company. We also place strong emphasis on employee development and environmental protection, and steadily advance our responsible practices.   The Group’s […]
CMS Recognized in S&P Global Sustainability Yearbook for Second Consecutive Year

CMS Recognized in S&P Global Sustainability Yearbook for Second Consecutive Year

2026-02-25

Recently, S&P Global, an internationally authoritative rating agency, has released the Sustainability Yearbook 2026 (the “Yearbook”). China Medical System (“CMS” or the “Group”) has stood out among 9,200 participating companies and successfully secured a place in the Yearbook, with a 2025 Corporate Sustainability Assessment (CSA) score of 66, surpassing 92% of global peers. This marks the second consecutive year that CMS has earned this international honor.   Source: S&P Global   Guided by its long-term ESG strategic objectives, CMS has deeply integrated the concept of sustainable development into its strategic decision-making and daily operations. The Group is driven by the dual engines of in-house R&D and collaborative R&D, continuously enhancing the accessibility and affordability of healthcare services and working to narrow health disparities across different regions and populations. Concurrently, we actively fulfill our corporate social responsibilities, leveraging innovative biotechnology to drive industry advancement and contribute to the sustained improvement of social well-being. Our sustainability performance has also been recognized by multiple authoritative rating agencies: MSCI ESG Rating maintained at “AA”; the Hong Kong […]

ESG Honors | CMS Awarded “2025 ESG Exemplary Enterprise Award” at the International Green Zero-Carbon Festival

2025-08-13

On July 18, 2025, at “The 4th International Green Zero-Carbon Festival & 2025 ESG Leadership Summit” held in Shanghai, China Medical System Holdings Limited (“CMS” or “the Group”) was honored with the “2025 ESG Exemplary Enterprise Award”. This award recognizes enterprises demonstrating systematic and pioneering practices across environmental, social, and governance dimensions. With its clear ESG strategy framework, quantifiable results, and continuous improvement mechanism, CMS has once again been highly recognized by authoritative institutions and the industry. Source: International Green Zero-Carbon Festival Official Website   With the theme of “Advancing Green Development, Toward Zero-Carbon Future”, the summit brought together over 200 enterprises and more than 100 industry leaders to discuss the industrial opportunities and transformation pathways under the dual carbon goal. This award is a full recognition of CMS’s long-term commitment to ESG values and innovation-driven sustainable development.   CMS has fully integrated the United Nations Sustainable Development Goals (SDGs) into the Group’s strategy, using top-level design to drive […]
CMS Charity | Lighting Up the Stars for Exceptional Children and Rural Education with Love

CMS Charity | Lighting Up the Stars for Exceptional Children and Rural Education with Love

2025-06-02

As the International Children’s Day approaches, China Medical System Holdings Limited (“CMS”)  has once again partnered with the Charity Association of Shenzhen Nanshan to visit Shenzhen Nanshan Star Exceptional Children Rehabilitation Center and Shenzhen Nanshan Exceptional Children Care Center, donating dedicated funds to both institutions. The donation will be used to purchase toys and teaching aids, upgrade office facilities, and sponsor advanced training for outstanding teachers to enhance the professionalism of special education staff. CMS has continuously supported the growth and development of exceptional children, and is wholeheartedly committed to playing a role in fostering a learning environment brimming with love and warmth for the children. Simultaneously, CMS is actively responding to China’s “Hundreds, Thousands, Tens of Thousands Project,” which aims to promote rural revitalization. Through the Guangdong Education Foundation, CMS has donated a total of 18 sets of laptops and desktop computers to Caojiang No. 2 Middle School in Gaozhou for the construction of a Loving Language Laboratory, enabling students to better […]

China Medical System has been Included in the S&P Global Sustainability Yearbook (China Edition) for the 3rd Consecutive Year

2025-04-15

On April 15, 2025, S&P Global officially released the Sustainability Yearbook (China Edition) 2025. China Medical System Holdings Limited (“CMS” or the “Group”) has stood out among over 1,600 Chinese companies with its outstanding performance in environmental, social, and governance (ESG) practices, marking its third consecutive year of inclusion in the Yearbook. Source: S&P Global   CMS has been implementing the concept of sustainable development into its strategy formulation and daily operation, focusing on unmet healthcare needs to provide better treatment solutions for doctors and patients, and striving to improve the accessibility and affordability of pharmaceutical products. At the same time, the Group has been continuously optimizing its internal governance, upholding the bottom line of product responsibility, respecting and empowering employees, and actively participating in public welfare, charity, and environmental protection activities, thus promoting a virtuous cycle of corporate development and responsibility fulfillment.   Through persistent dedication to sustainable development, […]
China Medical System is Included in the S&P Global Sustainability Yearbook 2025

China Medical System is Included in the S&P Global Sustainability Yearbook 2025

2025-02-13

In February 11th 2025, with a Corporate Sustainability Assessment (CSA) score of 61, surpassing 93% of global peers, China Medical System Holdings Limited (“CMS” or the “Group”) has been included in the S&P Global Sustainability Yearbook 2025 (the “Yearbook 2025”). This marks the Group’s first inclusion in the global edition of S&P Global Sustainability Yearbook (the “Yearbook”), following the S&P Global Sustainability Yearbook (China Edition) inclusion for consecutive two years.   Source: S&P Global   Since its launch in 2008, the Yearbook’s professionalism and authority have been highly recognized by global ESG investors and other stakeholders. The Yearbook aims to identify outstanding companies in sustainable development from each industry. 7,690 companies across 62 industries were assessed, while only 780 stood out and were included in the Yearbook 2025. The inclusion in the Yearbook 2025 represents a high recognition of sustainable development practices of CMS.   CMS has been actively responding […]

CMS Donated About RMB2.5 Million Worth of Special Fund and Supplies to Aid the Earthquake-stricken Area in Shigatse, Tibet

2025-01-13

On 7 January 2025, a magnitude 6.8 earthquake, which struck at a depth of 10 km, hit Tingri County, Shigatse City in Tibet, causing heavy casualties and house damages. Caring about the disaster, China Medical System Holdings Limited (“CMS”) has made proactive disaster relief efforts through its wholly-owned subsidiary, Tibet Kangzhe Pharmaceutical Development Co., Ltd. On January 9th, it donated relief supplies worth nearly RMB 0.5 million to the earthquake-stricken area through Tibet Development Philanthropic Foundation, including disinfectant, military coats, cotton quilts, and cotton jackets, etc. Moreover, on January 13th, it donated a special fund of RMB2 million to Tibet Charity Federation for post-disaster resettlement and reconstruction, to further help the disaster area to overcome the difficulties sooner.   Join hands to fight the disaster, and pray for peace and safety. CMS wishes the earthquake-stricken area in Shigatse, Tibet rebuild their homes as earlier as possible.  
China Medical System Included in the “Top 20 Chinese Pharmaceutical Listed Companies in ESG Competitiveness” for Three Consecutive Years, with New Honor of the “Top 10 Low-Carbon Pioneers”

China Medical System Included in the “Top 20 Chinese Pharmaceutical Listed Companies in ESG Competitiveness” for Three Consecutive Years, with New Honor of the “Top 10 Low-Carbon Pioneers”

2024-10-21

Recently, Healthcare Executive (“E药经理人”), in collaboration with a leading independent corporate social responsibility consulting agency in China, released the results of 2024 “Chinese Pharmaceutical Listed Companies ESG Competitiveness” series ranking. The ranking aims to recognize Chinese pharmaceutical companies that serve as benchmarks in various aspects of ESG management. By virtue of its continuous efforts in sustainable development and low-carbon initiatives, China Medical System (“CMS” or the “Group”) has been selected into the “Top 20 Chinese Pharmaceutical Listed Companies in ESG Competitiveness (Mid-cap Stocks)” ranking for three consecutive years, and has also been included in the inaugural “Top 10 Low-Carbon Pioneers of Chinese Pharmaceutical Listed Companies” ranking.     As an active practitioner of the sustainable development concept, CMS steadily responds to the United Nations Sustainable Development Goals, and promotes the deep integration of ESG governance with its macro strategies and business operations. With adherence to high standards of business ethics in its operations, the Group has established a scientific and effective risk identification […]

China Medical System Reincluded in S&P Global Sustainability Yearbook (China Edition) and Maintained MSCI ESG “AA” Rating

2024-07-16

In July 2024, China Medical System Holdings Limited (“CMS” or the “Group”) has once again been recognized for its outstanding performance and continuous progress in sustainable development. CMS was reincluded in the 2024 Sustainability Yearbook (China Edition) issued by S&P Global, a global-leading corporate sustainability assessment institution, and maintained its “AA” rating in the updated MSCI (Morgan Stanley Capital International) ESG Rating Report.   Re-including in S&P Global’s Sustainability Yearbook (China Edition) The S&P Global’s 2024 Sustainability Yearbook (China Edition) has been released. With an CSA score of 51 that surpassing 91% global peers in the industry, CMS stood out among more than 1,700 evaluated Chinese companies to be reincluded in the China Yearbook, becoming one of the five selected companies in the pharmaceutical industry. Source: S&P Global Receiving “AA” once again in MSCI ESG Rating In July, MSCI has released the latest ESG rating report for CMS. The Group […]